BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23064291)

  • 1. Impact of early detection and treatment of diabetes on the 6-year prevalence of cardiac autonomic neuropathy in people with screen-detected diabetes: ADDITION-Denmark, a cluster-randomised study.
    Charles M; Fleischer J; Witte DR; Ejskjaer N; Borch-Johnsen K; Lauritzen T; Sandbaek A
    Diabetologia; 2013 Jan; 56(1):101-8. PubMed ID: 23064291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of neuropathy and peripheral arterial disease and the impact of treatment in people with screen-detected type 2 diabetes: the ADDITION-Denmark study.
    Charles M; Ejskjaer N; Witte DR; Borch-Johnsen K; Lauritzen T; Sandbaek A
    Diabetes Care; 2011 Oct; 34(10):2244-9. PubMed ID: 21816977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial.
    Griffin SJ; Rutten GEHM; Khunti K; Witte DR; Lauritzen T; Sharp SJ; Dalsgaard EM; Davies MJ; Irving GJ; Vos RC; Webb DR; Wareham NJ; Sandbæk A
    Lancet Diabetes Endocrinol; 2019 Dec; 7(12):925-937. PubMed ID: 31748169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High and low vitamin D level is associated with cardiovascular autonomic neuropathy in people with Type 1 and Type 2 diabetes.
    Hansen CS; Fleischer J; Vistisen D; Ridderstråle M; Jensen JS; Jørgensen ME
    Diabet Med; 2017 Mar; 34(3):364-371. PubMed ID: 27696502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial.
    Griffin SJ; Borch-Johnsen K; Davies MJ; Khunti K; Rutten GE; Sandbæk A; Sharp SJ; Simmons RK; van den Donk M; Wareham NJ; Lauritzen T
    Lancet; 2011 Jul; 378(9786):156-67. PubMed ID: 21705063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of early multifactorial therapy compared with routine care on microvascular outcomes at 5 years in people with screen-detected diabetes: a randomized controlled trial: the ADDITION-Europe Study.
    Sandbæk A; Griffin SJ; Sharp SJ; Simmons RK; Borch-Johnsen K; Rutten GE; van den Donk M; Wareham NJ; Lauritzen T; Davies MJ; Khunti K
    Diabetes Care; 2014 Jul; 37(7):2015-23. PubMed ID: 24784827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paper electrocardiograph strips may contain overlooked clinical information in screen-detected type 2 diabetes patients.
    Fleischer J; Charles M; Tarnow L; Jensen KS; Nygaard H; Sandbaek A; Ejskjaer N
    J Diabetes Sci Technol; 2012 Jan; 6(1):74-80. PubMed ID: 22401325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin B12 deficiency is associated with cardiovascular autonomic neuropathy in patients with type 2 diabetes.
    Hansen CS; Jensen JS; Ridderstråle M; Vistisen D; Jørgensen ME; Fleischer J
    J Diabetes Complications; 2017 Jan; 31(1):202-208. PubMed ID: 27638143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes and cardiac autonomic neuropathy screening using dynamic pupillometry.
    Lerner AG; Bernabé-Ortiz A; Ticse R; Hernandez A; Huaylinos Y; Pinto ME; Málaga G; Checkley W; Gilman RH; Miranda JJ;
    Diabet Med; 2015 Nov; 32(11):1470-8. PubMed ID: 25761508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of early intensive multifactorial therapy compared with routine care on self-reported health status, general well-being, diabetes-specific quality of life and treatment satisfaction in screen-detected type 2 diabetes mellitus patients (ADDITION-Europe): a cluster-randomised trial.
    Van den Donk M; Griffin SJ; Stellato RK; Simmons RK; Sandbæk A; Lauritzen T; Khunti K; Davies MJ; Borch-Johnsen K; Wareham NJ; Rutten GE
    Diabetologia; 2013 Aug; 56(11):2367-77. PubMed ID: 23959571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ADDITION-Cambridge trial protocol: a cluster -- randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients.
    Echouffo-Tcheugui JB; Simmons RK; Williams KM; Barling RS; Prevost AT; Kinmonth AL; Wareham NJ; Griffin SJ
    BMC Public Health; 2009 May; 9():136. PubMed ID: 19435491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of sexual desire and satisfaction among patients with screen-detected diabetes and impact of intensive multifactorial treatment: results from the ADDITION-Denmark study.
    Pedersen MB; Giraldi A; Kristensen E; Lauritzen T; Sandbæk A; Charles M
    Scand J Prim Health Care; 2015 Mar; 33(1):3-10. PubMed ID: 25659194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for the Presence and Progression of Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: ADDITION-Denmark.
    Andersen ST; Witte DR; Fleischer J; Andersen H; Lauritzen T; Jørgensen ME; Jensen TS; Pop-Busui R; Charles M
    Diabetes Care; 2018 Dec; 41(12):2586-2594. PubMed ID: 30305347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal symptom burden in diabetic autonomic and peripheral neuropathy - A Danes cohort study.
    Kufaishi H; Mizrak HI; Brock B; Hansen TW; Rossing P; Hansen CS
    J Diabetes Complications; 2024 May; 38(5):108745. PubMed ID: 38615421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association and predictive value analysis for resting heart rate and diabetes mellitus on cardiovascular autonomic neuropathy in general population.
    Tang ZH; Zeng F; Li Z; Zhou L
    J Diabetes Res; 2014; 2014():215473. PubMed ID: 24772443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo corneal confocal microscopy as a novel non-invasive tool to investigate cardiac autonomic neuropathy in Type 1 diabetes.
    Maddaloni E; Sabatino F; Del Toro R; Crugliano S; Grande S; Lauria Pantano A; Maurizi AR; Palermo A; Bonini S; Pozzilli P; Manfrini S
    Diabet Med; 2015 Feb; 32(2):262-6. PubMed ID: 25251450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does training of general practitioners for intensive treatment of people with screen-detected diabetes have a spillover effect on mortality and cardiovascular morbidity in 'at risk' individuals with normoglycaemia? Results from the ADDITION-Denmark cluster-randomised controlled trial.
    Simmons RK; Bruun NH; Witte DR; Borch-Johnsen K; Jørgensen ME; Sandbæk A; Lauritzen T
    Diabetologia; 2017 Jun; 60(6):1016-1021. PubMed ID: 28280901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of heart-rate recovery after exercise in the assessment of diabetic cardiac autonomic neuropathy.
    Sacre JW; Jellis CL; Coombes JS; Marwick TH
    Diabet Med; 2012 Sep; 29(9):e312-20. PubMed ID: 22671998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropad for the detection of cardiovascular autonomic neuropathy in patients with type 2 diabetes.
    Mendivil CO; Kattah W; Orduz A; Tique C; Cárdenas JL; Patiño JE
    J Diabetes Complications; 2016; 30(1):93-8. PubMed ID: 26525688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How good are GPs at adhering to a pragmatic trial protocol in primary care? Results from the ADDITION-Cambridge cluster-randomised pragmatic trial.
    Laxy M; Wilson ECF; Boothby CE; Griffin SJ
    BMJ Open; 2018 Jun; 8(6):e015295. PubMed ID: 29903781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.